Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
14
NMPA:14
Drug Approvals
Ursodeoxycholic Acid Capsules
- Product Name
- 熊去氧胆酸胶囊
- Approval Number
- 国药准字H20253459
- Approval Date
- Feb 25, 2025
NMPA
Choline Fenofibrate Sustained-release Capsules
- Product Name
- 非诺贝特酸胆碱缓释胶囊
- Approval Number
- 国药准字H20253261
- Approval Date
- Jan 24, 2025
NMPA
Choline Fenofibrate Sustained-release Capsules
- Product Name
- 非诺贝特酸胆碱缓释胶囊
- Approval Number
- 国药准字H20253262
- Approval Date
- Jan 24, 2025
NMPA
Oseltamivir Phosphate for Suspension
- Product Name
- 磷酸奥司他韦干混悬剂
- Approval Number
- 国药准字H20253138
- Approval Date
- Jan 14, 2025
NMPA
Oseltamivir Phosphate Capsules
- Product Name
- 磷酸奥司他韦胶囊
- Approval Number
- 国药准字H20249360
- Approval Date
- Nov 15, 2024
NMPA
Sugammadex Sodium Injection
- Product Name
- 舒更葡糖钠注射液
- Approval Number
- 国药准字H20249085
- Approval Date
- Oct 16, 2024
NMPA
Metoprolol succinate Sustained-release Capsules
- Product Name
- 琥珀酸美托洛尔缓释胶囊
- Approval Number
- 国药准字H20249096
- Approval Date
- Oct 16, 2024
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found